177 related articles for article (PubMed ID: 20554797)
1. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
Wang X; Liu X; Jia Y; Chao Y; Xing X; Wang Y; Luo B
J Gen Virol; 2010 Oct; 91(Pt 10):2564-73. PubMed ID: 20554797
[TBL] [Abstract][Full Text] [Related]
2. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
[TBL] [Abstract][Full Text] [Related]
3. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Han J; Chen JN; Zhang ZG; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(3):e34276. PubMed ID: 22470549
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan.
Wang Y; Kanai K; Satoh Y; Luo B; Sairenji T
Intervirology; 2007; 50(3):229-36. PubMed ID: 17356301
[TBL] [Abstract][Full Text] [Related]
5. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
6. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
7. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
8. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
9. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China.
Wang Y; Zhang X; Chao Y; Jia Y; Xing X; Luo B
J Med Virol; 2010 May; 82(5):829-36. PubMed ID: 20336720
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
11. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of gastric carcinoma cell clones expressing LMP2A of Epstein-Barr virus.
Seo JS; Jun SM; Kwon SW; Oh IH; Kim TG; Lee SK
Int J Mol Med; 2010 Jan; 25(1):11-6. PubMed ID: 19956896
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
[TBL] [Abstract][Full Text] [Related]
14. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
Wang Y; Wang XF; Sun ZF; Luo B
Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
[TBL] [Abstract][Full Text] [Related]
18. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China.
Wu G; Wang Y; Chao Y; Jia Y; Zhao C; Luo B
Arch Virol; 2012 May; 157(5):845-53. PubMed ID: 22302288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
